Physician profile
Michael Kozminski
NPI 1750678264
$6,626.82
in general payments reported to CMS, 2019-2025
56 companies · $908 in 2025
The $908 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,231 · 2020: $695 · 2021: $780 · 2022: $914 · 2023: $1,344 · 2024: $754 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,972 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,971.84 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $828.05 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Coloplast Corp | $541.67 | 2019-2025 | Speedicath, Porges Coloplast |
| Janssen Biotech, INC. | $519.98 | 2019-2025 | Erleada, Balversa, Akeega |
| Abbvie INC. | $498.86 | 2019-2025 | |
| Pfizer INC. | $403.18 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $337.12 | 2023-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $254.15 | 2021-2022 | |
| Amgen INC. | $226.34 | 2019-2023 | Xgeva |
| Neotract INC. | $216.40 | 2019 | |
| Caldera Medical, INC | $214.51 | 2022-2023 | Desara |
| Boston Scientific Corporation | $205.68 | 2019-2023 | Lithovue, Ams 700 Cxr Rte Kit |
| Antares Pharma, INC. | $164.30 | 2021-2025 | Xyosted |
| Blue Earth Diagnostics | $133.81 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $128.63 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.92 | 2019-2022 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kozminski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.